Cargando…

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome

We previously presented the protein-protein interaction network - the ‘HoP’ or the host protein interactome - of 332 host proteins that were identified to interact with 27 nCoV19 viral proteins by Gordon et al. Here, we studied drugs targeting the proteins in this interactome to identify whether any...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karunakaran, Kalyani B., Balakrishnan, N., Ganapathiraju, Madhavi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336709/ https://www.ncbi.nlm.nih.gov/pubmed/32702734 http://dx.doi.org/10.21203/rs.3.rs-30363/v1

Ejemplares similares

Potentially repurposable drugs for schizophrenia identified from its interactome
por: Karunakaran, Kalyani B., et al.
Publicado: (2019)

Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs
por: Karunakaran, Kalyani B., et al.
Publicado: (2020)

Generalized and social anxiety disorder interactomes show distinctive overlaps with striosome and matrix interactomes
por: Karunakaran, Kalyani B., et al.
Publicado: (2021)

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
por: Sadegh, Sepideh, et al.
Publicado: (2020)

Malignant Pleural Mesothelioma Interactome with 364 Novel Protein-Protein Interactions
por: Karunakaran, Kalyani B., et al.
Publicado: (2021)

Cilia interactome with predicted protein–protein interactions reveals connections to Alzheimer’s disease, aging and other neuropsychiatric processes
por: Karunakaran, Kalyani B., et al.
Publicado: (2020)

Schizophrenia interactome: fully-labeled interactome network
por: Ganapathiraju, Madhavi, et al.
Publicado: (2016)

Predicted protein interactions of IFITMs may shed light on mechanisms of Zika virus-induced microcephaly and host invasion
por: Ganapathiraju, Madhavi K., et al.
Publicado: (2017)

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

The Host Interactome of Spike Expands the Tropism of SARS-CoV-2
por: Bamberger, Casimir, et al.
Publicado: (2021)

Novel Protein–Protein Interactions Highlighting the Crosstalk between Hypoplastic Left Heart Syndrome, Ciliopathies and Neurodevelopmental Delays
por: Karunakaran, Kalyani B., et al.
Publicado: (2022)

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
por: Anand, Nithishwer Mouroug, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
por: Sun, Lei, et al.
Publicado: (2021)

Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
por: Ahsan, Tamim, et al.
Publicado: (2021)

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
por: Abuo-Rahma, Gamal El-Din A., et al.
Publicado: (2020)

F200. ELUCIDATING THE ROLE OF CILIA IN NEUROPSYCHIATRIC DISEASES THROUGH INTERACTOME ANALYSIS
por: Ganapathiraju, Madhavi, et al.
Publicado: (2018)

Interactomes of SARS‐CoV‐2 and human coronaviruses reveal host factors potentially affecting pathogenesis
por: Chen, Zhen, et al.
Publicado: (2021)

Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
por: Hoffmann, H.-Heinrich, et al.
Publicado: (2021)

Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis
por: Das, Jayanta Kumar, et al.
Publicado: (2021)

A reference catalog of DNA palindromes in the human genome and their variations in 1000 Genomes
por: Ganapathiraju, Madhavi K., et al.
Publicado: (2020)

The SARS-CoV-2 RNA interactome
por: Lee, Sungyul, et al.
Publicado: (2021)

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
por: Patocka, Jiri, et al.
Publicado: (2021)

Mycobacterium tuberculosis and Clostridium difficille interactomes: demonstration of rapid development of computational system for bacterial interactome prediction
por: Ananthasubramanian, Seshan, et al.
Publicado: (2012)

Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021)

Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
por: Ku, Keun Bon, et al.
Publicado: (2020)

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
por: Tummino, Tia A., et al.
Publicado: (2021)

Tackling SARS-CoV-2: proposed targets and repurposed drugs
por: Joshi, Siddhi, et al.
Publicado: (2020)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Applying polypharmacology approach for drug repurposing for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2022)

Drug repurposing for SARS-CoV-2 (COVID-19) treatment
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Improved and optimized drug repurposing for the SARS-CoV-2 pandemic
por: Cohen, Sarel, et al.
Publicado: (2023)

Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
por: Belyaeva, Anastasiya, et al.
Publicado: (2021)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022)

Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
por: Li, Jingjiao, et al.
Publicado: (2021)

Integrative In Silico Investigation Reveals the Host-Virus Interactions in Repurposed Drugs Against SARS-CoV-2
por: Yu, Wenhui, et al.
Publicado: (2022)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
por: Ahmed, Fee Faysal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gvmquepelufbijr2dv986r2g6j